Nymox Pharmaceutical Corporation (NASDAQ:NYMX) holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of Alzheimer’s disease (AD), including for patients at risk for AD because of vascular-related risk factors or disease. An important new study has found that ongoing statin drug use was associated with a 67% reduction in the risk of AD (Current Alzheimer Research 2008; 5: 416-421).

Title: Health Tip: Communicating With a Loved One’s DoctorbrCategory: Health NewsbrCreated: 10/24/2008 2:00:00 AMbrLast Editorial Review: 10/24/2008

Title: Health Tip: Risk Factors for Heart DiseasebrCategory: Health NewsbrCreated: 10/24/2008 2:00:00 AMbrLast Editorial Review: 10/24/2008

Title: 50% of Doctors Prescribe PlacebosbrCategory: Health NewsbrCreated: 10/24/2008brLast Editorial Review: 10/24/2008

Title: High Fructose Diet Inhibits Appetite HormonebrCategory: Health NewsbrCreated: 10/24/2008 2:00:00 AMbrLast Editorial Review: 10/24/2008

Title: Standard Hepatitis C Treatment Cost-Effective for PrisonersbrCategory: Health NewsbrCreated: 10/24/2008 2:00:00 AMbrLast Editorial Review: 10/24/2008

Title: U.S. Urged to Renew the War on CancerbrCategory: Health NewsbrCreated: 10/24/2008 2:00:00 AMbrLast Editorial Review: 10/24/2008

Title: Experimental Pill May Treat MSbrCategory: Health NewsbrCreated: 10/24/2008brLast Editorial Review: 10/24/2008

Title: Health Highlights: Oct. 23, 2008brCategory: Health NewsbrCreated: 10/24/2008 2:00:00 AMbrLast Editorial Review: 10/24/2008

Title: Speedy Care After Heart Attack Key to SurvivalbrCategory: Health NewsbrCreated: 10/24/2008 2:00:00 AMbrLast Editorial Review: 10/24/2008